skip to content

e-Therapeutics

16:55 on 20/11/2017

Current Price 9.42p | Bid 9.25p | Ask 9.50p | Change 0.00%

Company Overview

e-Therapeutics plc is a drug discovery company. It has a proprietary systems biology technology which it uses to discover potential new treatments for diseases for which either there are no existing treatments or current treatments are unsatisfactory. The Directors' strategy is to develop such treatments to the point of premium value and then to license them to pharmaceutical partners. The Company's approach is to use computer technology to accomplish drug discovery as quickly, systematically and efficiently as possible. Its aim is to generate, with increasing efficiency, a drug pipeline of high-quality new treatments. Its focus is on increasing the speed and accuracy with which new candidate drugs for these diseases are generated and evaluated for efficacy and safety; and on increasing the probability of success of these candidates in drug development by evaluating as many risks as possible early in development. The Company's drug discovery platform can be used to discover new drug compounds, alternative indications for existing compounds and combinations of compounds. Its main country of operation is the United Kingdom.

Stock Details

EPIC ETX
ISIN GB00B2823H99
Shares in Issue 268,312,286
Market cap £ 30.86m
Sector Pharmaceuticals & Biotechnology
Indices FTSE AIM All-Share Index

Financial Highlights Year Ended 31/01/2016

Turnover £0.00 million
Operating Profit £-11.56 million
Dividend Yield 0.00
Dividend Per Share 0.00
Dividend Cover 0.00
P/E Ratio -3.44
» More Financials

Key Personnel

Professor Malcolm Young CEO
Daniel Elger CFO

Info Point:

To buy or sell shares call our Dealing Room on 0113 243 6941

Too much jargon? Our glossary will help make sense of things.

Find out more about our Share Dealing Services.

Price Summary

Mid Price ? 9.38p
Bid Price ? 9.25p
Ask Price ? 9.50p
Volume ? 35238
Change Today 0.00p
% Change Today 0.00%
Open 9.25p
Previous Close 9.38p
Intraday High 9.42p
Intraday Low 9.25p
52 Week High 38.00p
52 Week Low 9.50p

Intra-Day Chart

More Charts »

Broker Consensus

The above information represents a selection of the views and target prices published in the last 120 days by analysts in individual stocks. It is subject to change without notice and may not necessarily be the view held by Redmayne-Bentley.

Client Area Access

» Secure Login

» Not registered yet?

Branch Finder

Redmayne-Bentley have High Street branches throughout the UK. Find your nearest branch.